Öffentliche Research-Berichte

Costco Wholesale Corporation

COSTNASDAQ

Halten

Hold current position; use $935–$938 as tactical probe zone and $925 as stop/reduce level.

Arcturus Therapeutics Holdings, Inc.

ARCTNASDAQ

Halten

Hold current position pending definitive LUNAR-CF clinical data and regulatory guidance at the November 11, 2026 earnings call.

OmniAb, Inc.

OABINASDAQ

Halten

Hold current position with strict trailing stop-loss at $4.40 to balance participation in momentum with capital protection.

Moderna, Inc.

MRNANASDAQ

Halten

Hold MRNA with adjusted risk controls: reduce position size by 30%, move stop-loss to $130, and add a protective put.

Aveanna Healthcare Holdings Inc

AVAHNASDAQ

Halten

Hold current position in AVAH while awaiting Q3 earnings for concrete evidence of debt reduction progress.

AtaiBeckley Inc.

ATAINASDAQ

Halten

Hold current position with disciplined risk management: maintain exposure, set stop at $7.10, and take partial profits at $7.45–$7.50.

AtriCure, Inc.

ATRCNASDAQ

Untergewichten

Reduce exposure by 30% now; hold remainder with $43.00 stop-loss and wait for pullback confirmation before re-entry.

ARC Group Acquisition I Corp Class A

ARCLNASDAQ

Verkaufen

Sell immediately: ARCL is structurally overvalued with no credible path to close its merger before liquidation.

StoneBridge Acquisition II Corporation Class A

APACNASDAQ

Kaufen

Portfolio Manager’s Final Trading Decision: APAC (StoneBridge Acquisition II Corporation Class A)

Amylyx Pharmaceuticals, Inc.

AMLXNASDAQ

Halten

Portfolio Manager’s Final Trading Decision: AMLX

Apogee Acquisition Corp Class A

AACPNASDAQ

Halten

Hold current position; await definitive merger announcement or decisive technical breakout above $10.0633 with volume > 100K.

Lam Research Corporation

LRCXNASDAQ

Halten

Hold current position in LRCX pending resolution of key catalysts: Q4 earnings (Oct 21), confirmed close above $337.77 on high volume, and stabilization of insider selling.

Applied Materials, Inc.

AMATNASDAQ

Halten

Hold current position; await decisive technical confirmation above $520.26 or below $463.49 before adjusting exposure.

Cisco Systems, Inc.

CSCONASDAQ

Halten

Hold current position while awaiting resolution of the core margin–growth tension.

Walmart Inc.

WMTNASDAQ

Halten

Hold current position; use Q2 earnings on August 20 as the decisive catalyst for Overweight or Underweight action.

SELLAS Life Sciences Group, Inc.

SLSNASDAQ

Halten

Hold current position in SLS; await definitive GPS Phase 3 readout or technical breakout/breakdown for adjustment.

Climb Bio, Inc.

CLYMNASDAQ

Halten

Hold current position with disciplined price-based contingencies and catalyst-driven reassessment.

New Era Energy & Digital, Inc.

NUAINASDAQ

Halten

Hold current position; add only upon verified PPA or construction commencement with milestones.